Faced with a national opioid epidemic, researchers have found that wearable biosensors hold great promise for detecting episodes of drug use in real time with the potential for keeping opioid users on track with substance abuse treatment programs by triggering interventions in the event of a relapse.

The sensors, developed by Waltham, Mass.-based Affectiva, detect and record physiological signs of opioid use. A University of Massachusetts Medical School team tested the use of these wristband sensors worn by patients in an emergency room who were receiving opioids for severe pain relief.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access